GO Term | Evidence Code | PMID |
---|---|---|
positive regulation of osteoclast differentiation | ||
response to gold nanoparticle | ||
sequestering of triglyceride | ||
response to 3,3',5-triiodo-L-thyronine | ||
response to glucocorticoid |
GO Term | Evidence Code | PMID |
---|---|---|
extracellular region | ||
external side of plasma membrane | ||
neuronal cell body | ||
cell surface | ||
plasma membrane |
GO Term | Evidence Code | PMID |
---|---|---|
death receptor agonist activity | ||
cytokine activity | ||
tumor necrosis factor receptor binding | ||
protein binding | ||
transcription cis-regulatory region binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:874 | bacterial pneumonia | |
DOID:8778 | Crohn's disease | |
DOID:8893 | psoriasis | |
DOID:8947 | diabetic retinopathy | |
DOID:900 | hepatopulmonary syndrome | |
DOID:9008 | psoriatic arthritis | |
DOID:9074 | systemic lupus erythematosus | |
DOID:9111 | cutaneous leishmaniasis | |
DOID:9120 | amyloidosis | |
DOID:9146 | visceral leishmaniasis |
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
103270149 | CARSF17149 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024